2024 Evfm sec

Evfm sec

Author: ctsb

August undefined, 2024

WebApr 10, 2024 · Ticker: EVFM CIK: 1618835 Form Type: 8-K Corporate News Accession Number: 0001493152-23-011771 Submitted to the SEC: Mon Apr 10 2024 5:26:12 PM EST Accepted by the SEC: Mon Apr 10 2024 Period: Wednesday, April 5, 2024 Industry: Pharmaceutical Preparations Events: Event for Officers; Financial Exhibit; New … WebEVFM Complete Evofem Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Evofem Biosciences Announces Pricing of Approximately $26.6 …

WebDec 30, 2024 · Ticker: EVFM CIK: 1618835 Form Type: 8-K Corporate News Accession Number: 0001618835-22-000212 Submitted to the SEC: Fri Dec 30 2024 9:25:03 AM EST Accepted by the SEC: Fri Dec 30 2024 Period: Thursday, December 29, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External … WebApr 11, 2024 · 4 brokerages have issued twelve-month target prices for Evofem Biosciences' stock. Their EVFM share price forecasts range from $3.50 to $8.55. On average, they anticipate the company's stock price to reach $5.35 in the next year. This suggests a possible upside of 24,273.6% from the stock's current price. View analysts … surly attitude meaning

evfm-20241231 - SEC

WebMar 31, 2024 · As of March 31, 2024, the Baker Notes are recorded in the condensed consolidated balance sheet as short-term convertible notes payable with a total balance of $ 53.2 million. The balance is comprised of a $ 50.9 million fair value of the Baker Notes and $ 2.3 million in accrued interest. WebMar 21, 2024 · SAN DIEGO, March 21, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced it has implemented measures to lower its operating expenses, with the goal of ... WebView the EVFM U.S. Securities and Exchange Commission reporting information. Evofem Biosciences Inc. SEC filings breakout by MarketWatch. Skip to main content Main Menu surly axeman beer

Evfm sec

EVFM -- Is Its Stock Price A Worthy Investment? Learn More.

WebFeb 15, 2024 · Ticker: EVFM CIK: 1618835 Form Type: Proxy Statements Form DEF 14A Accession Number: 0001618835-23-000008 Submitted to the SEC: Wed Feb 15 2024 4:00:21 PM EST Accepted by the SEC: Wed Feb 15 2024 Period: Wednesday, March 15, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social … WebAug 4, 2024 · Evofem Biosciences, Inc., (Nasdaq: EVFM) ("Evofem" or the "Company"), today reported financial results for the three- and six-month periods ended June 30, 2024 and affirmed full-year 2024 guidance.

Did you know?

WebFind the latest Evofem Biosciences, Inc. (EVFM) stock quote, history, news and other vital information to help you with your stock trading and investing. WebGet Evofem Biosciences Inc (EVFM:OTCQB) real-time stock quotes, news, price and financial information from CNBC.

WebEX-101.SCH 2 evfm-20240405.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 evfm-20240405_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Document Type … WebUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2024 EVOFEM BIOSCIENCES, INC.

WebDec 31, 2024 · The aggregate market value of the common stock held by non‑affiliates of the registrant was approximately $ 172,915,009 as of June 30, 2024, based upon the … WebMar 30, 2024 · Latest SEC filings for Evofem Biosciences, Inc. (EVFM).

WebDec 31, 2024 · The aggregate market value of the common stock held by non‑affiliates of the registrant was approximately $ 190,546,003 as of June 30, 2024, based upon the closing sale price on the Nasdaq Capital …

WebJun 30, 2024 · EVFM: The Nasdaq Stock Market LLC (Nasdaq Capital Market) Series A Preferred Stock Purchase Rights, par value $0.0001 per share: N/A: ... 2024 included in its Annual Report on Form 10-K as filed with the SEC on March 10, 2024 (the 2024 Audited Financial Statements). ... surly baselayer merinoWebEvofem Biosciences Inc. SEC filings breakout by MarketWatch. View the EVFM U.S. Securities and Exchange Commission reporting information. surly beargrease surly bbqWebApr 10, 2024 · 0001618835 2024-04-05 2024-04-05 iso4217:USD xbrli:shares iso4217:USD surly bartenderWebMay 20, 2024 · Evofem Biosciences Announces Pricing of Approximately $26.6 Million Public Offering. SAN DIEGO, May 20, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced … surly bearWebMar 10, 2024 · SAN DIEGO, March 3, 2024 - Evofem Biosciences, Inc. (Nasdaq: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the … surly australiaWebMay 20, 2024 · PR Newswire. SAN DIEGO, May 20, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced the pricing of its previously announced underwritten public offering of ... surly bender clone